| Literature DB >> 27869806 |
B L Fife1, D M Von Ah2, M L Spath2, M T Weaver3, Z Yang4, T Stump4, S Farag5.
Abstract
The primary purpose of this research was to develop and evaluate the efficacy and feasibility of a brief, cost-effective family-focused intervention to promote adaptive coping and quality of life throughout a parent's bone marrow transplantation (BMT). Targeted outcomes were cohesion, decreased use of avoidance coping, open communication and effective management of emotional distress. Participants included an intervention group of 31 families and 29 families in a control group who received usual care. Each family included the BMT recipient, a partner/caregiver and children 10-18 years old. The intervention included two dyadic sessions for the BMT recipient and the partner/caregiver, one individual session for the caregiver and two digital video discs (DVDs) for children. Statistical analyses indicated that the intervention had a positive impact on at least one aspect of the adaptation of each family member. Caregivers reported the most distress but benefitted least from the intervention, whereas recipients and children reported improvement in distress. Ratings of satisfaction/acceptability were high, with 97% responding that they would recommend the intervention to others. Plans for future research include increased intervention intensity for the caregiver, a larger more diverse sample and implementation over an extended period post BMT.Entities:
Mesh:
Year: 2016 PMID: 27869806 PMCID: PMC5288293 DOI: 10.1038/bmt.2016.267
Source DB: PubMed Journal: Bone Marrow Transplant ISSN: 0268-3369 Impact factor: 5.483
Demographic Characteristics of the BMT Recipient and Caregiver by Treatment Group at Baseline
| BMT Recipient | Caregiver | |||||
|---|---|---|---|---|---|---|
| Characteristics | Intervention (n = 31)[ | Control (n = 29)[ | P value[ | Intervention (n = 31)[ | Control (n = 29)[ | P value[ |
|
| 45.53 (6.45) | 46.74 (6.78) | 0.486 | 43.91 (6.83) | 44.64 (5.96) | 0.661 |
|
| ||||||
| Female | 12 (38.71) | 8 (27.5) | 0.361 | 19 (61.29) | 20 (68.97) | 0.533 |
| Male | 19 (61.29) | 21 (72.41) | 12 (38.71) | 9 (31.03) | ||
|
| ||||||
| Caucasian | 27 (87.10) | 25 (86.21) | 0.430 | 28 (90.32) | 27 (93.10) | >0.999 |
| Non-Caucasian | 0 | 2 (6.90) | 2 (6.45) | 2 (6.90) | ||
| More than 1 Race | 4 (12.90) | 2 (6.90) | 1 (3.23) | 0 | ||
|
| ||||||
| Married | 29 (90.32) | 29 (100.00) | 0.238 | 28 (90.32) | 29 (100.00) | 0.238 |
| Living with Partner | 3 (9.68) | 0 | 3 (9.68) | 0 | ||
|
| ||||||
| Grade 8 or less | 1 (3.23) | 0 | 0.596 | 0 | 0 | 0.242 |
| High School | 9 (29.03) | 4 (14.29) | 11 (35.48) | 8 (27.59) | ||
| Vocational/Technical School | 5 (16.13) | 6 (21.43) | 2 (6.45) | 2 (6.90) | ||
| Some College | 7 (22.58) | 8 (28.57) | 10 (32.26) | 4 (13.79) | ||
| Four Year College Degree | 8 (25.81) | 7 (25.00) | 7 (22.58) | 11 (37.93) | ||
| Graduate Degree | 1 (3.23) | 3 (10.71) | 1 (3.23) | 4 (13.79) | ||
|
| ||||||
| Autologous | 6 (19.35) | 11 (37.93) | 0.0007 | NA | NA | NA |
| Allogeneic | 25 (80.65) | 18 (62.07) | NA | NA | ||
Abbreviations: BMT, bone marrow transplantation. NA, not applicable.
Data are expressed as No. (%).
Significantly different at P < 0.05.
Figure 1A Theoretical Model of Adaptation to BMT within the Family Context
Table of Measures
| Variable | Measure | Description of Measure | Cronbach's Alpha | |||
|---|---|---|---|---|---|---|
| BMT recipient | Partner | Children | ||||
|
| ||||||
| Socio-demographics and Illness Factors | Demographic Questionnaire | Items included socio-demographic information (family participants' ages, gender, race, education), marital status of the patient and caregiver, family annual income, and the patient's illness information (diagnosis, type of transplant). Data obtained at Time 1 from BMT recipient and/or partner. | X | X | ||
|
| ||||||
| Emotional Status | The Positive and Negative Affect Schedule (PANAS): Negative Affect Subscale Watson, Clark, & Tellegen, 1988 (Ref. | 10 items - Negative affect as an indicator of parent distress. Participants rate how often they have experienced specific negative emotions (upset, sadness, scared, nervous) over the past two weeks prior to data collection. Ranked on a 5-point Likert scale with item responses ranging from “very slightly/not at all” to “extremely”. | X | X | .88 | |
| The Child Health Questionnaire (CHQ-CF87): Mental Health Subscale Landgraf, Abetz, & Ware, 1996 (Ref. | 16 items pertaining to feelings: happy, sad, scared, lonely over the previous two weeks prior to data collection. Participants rated the frequency of these on a 5-point scale, with item responses ranging from “none of the time” to “all of the time”. | X | .82 | |||
|
| ||||||
| Avoidance Coping | Ways of Coping Checklist Avoidance Subscale Lazarus & Folkman, 1984 (Ref. | 8 item subscale assessing the use of avoidance coping from a modified version of the Ways of Coping Checklist. Items included the frequency of the use of avoiding others, wishful thinking, distraction. Responses were ranked on a 5-point scale by the participant to indicate the frequency of use (“never” to “very often”) of each behavior over the previous two weeks. | X | X | .83 | |
| Response to Stress Questionnaire (RSQ): Disengagement Subscale Connor-Smith, J., Compas, B. Wadsworth, M. Thomson, A. & Salzman, H. 2000 (Ref. | Nine item subscale asking children to rank the frequency of their use of disengagement coping behaviors (denial, avoidance, wishful thinking) with regard to their own previously identified stress-related aspects of their parent's BMT. Children rated their use on a 4-point scale, ranging from “not at all” to “a lot”. | X | .73 | |||
| Communication | Family Environment Scale (FES): Expressiveness Subscale Moos & Moos, 2002 (Ref. | 9 items pertaining to the participants' perceptions of this construct for the two week time period prior to data collection. Items included: expressing feelings and concerns to one another, family discussion, and disclosure. Statements scored as “True” or “False”. | X | X | X | .69 adults |
|
| ||||||
| Family Cohesion | Family Environment Scale (FES) Subscale: Cohesion Moos & Moos, 2002 (Ref. | 9 items pertaining to the participants' perceptions of this construct in the family for the two week time period prior to data collection. Items included: togetherness, spirit, getting along, and mutual support. Statements scored as “True” or “False”. | X | X | X | .78 adults |
| Dyadic Adjustment | The Dyadic Adjustment Scale (DAS) Spanier, 1976 (ref. | 32 item scale measures four relational elements: satisfaction, cohesion, consensus, and affectional expression in a marital/committed relationship of the recipient and caregiver/partner. The total score was used. | X | X | .90 | |
Primary Outcomes with Group Equivalence at Baseline
| BMT Recipient | Caregiver | Child | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Outcomes | Intervention (n = 31)[ | Control (n = 29)[ | P value[ | Intervention (n = 31)[ | Control (n = 29)[ | P value[ | Intervention (n = 31)[ | Control (n = 27)[ | P value[ |
|
| 20.76 (7.29) | 22.18 (8.20) | 0.492 | 24.19 (9.11) | 25.50 (7.49) | 0.552 | 60.10 (10.08) | 58.41 (8.94) | 0.507 |
|
| 13.77 (5.34) | 13.28 (4.70) | 0.715 | 13.44 (5.22) | 15.42 (4.56) | 0.127 | 19.38 (5.21) | 17.81 (5.51) | 0.282 |
|
| 6.17 (1.84) | 5.88 (1.91) | 0.568 | 5.51 (1.91) | 5.96 (2.20) | 0.406 | 4.73 (1.82) | 4.47 (1.92) | 0.594 |
|
| 116.30 (15.66) | 118.60 (17.00) | 0.589 | 114.50 (16.88) | 114.30 (20.28) | 0.961 | NA | NA | NA |
Abbreviations: BMT, bone marrow transplantation.
Data are expressed as Mean (SD).
Significantly different at P < 0.05.
Sample Sizes for BMT Recipients and Caregivers at Each Data Point for Both Groups
| Family Member | Visit | Control (N=) | Intervention (N=) |
|---|---|---|---|
| Caregiver | Baseline | 29 | 31 |
| 1-Month Post | 26 | 19 | |
| 4-Months Post | 24 | 16 | |
| Child | Baseline | 27 | 31 |
| 1-Month Post | 25 | 22 | |
| 4-Months Post | 23 | 16 | |
| Recipient | Baseline | 29 | 31 |
| 1-Month Post | 25 | 19 | |
| 4-Months Post | 24 | 15 |
Within-group and Between-group Effect Sizes of Outcomes
| Within-Group Effects | Between-Group Effects | ||||
|---|---|---|---|---|---|
| Outcome [Measures] | Intervention (n=31) | Control (n=29) | |||
| Mean[ | Mean[ | ||||
|
| |||||
|
| |||||
| Baseline | 7.27 (6.00, 8.53) | 7.01 (5.77, 8.24) | |||
| 1- Month Post | 6.96 (5.33, 8.58) | −0.09 (−0.22, 0.05) | 7.14 (5.79, 8.49) | 0.04 (−0.07, 0.15) | −0.13 (−0.27, 0.01) |
| 4-Months Post | 8.83 (7.61, 10.04) | 0.43 (0.26, 0.61)[ | 7.22 (6.16, 8.28) | 0.06 (−0.05, 0.18) | 0.38 (0.20, 0.57)[ |
|
| |||||
| Baseline | 6.71 (5.32, 8.10) | 6.66 (5.25, 8.06) | |||
| 1- Month Post | 6.63 (4.78, 8.48) | −0.02 (−0.15, 0.11) | 6.67 (5.05, 8.30) | 0.005 (−0.11, 0.11) | −0.03 (−0.17, 0.11) |
| 4-Months Post | 7.60 (6.13, 9.08) | 0.23 (0.07, 0.38)[ | 6.63 (5.12, 8.13) | −0.01 (−0.13, 0.11) | 0.24 (0.07, 0.40)[ |
|
| |||||
| Baseline | 7.46 (6.40, 8.52) | 6.92 (5.71, 8.13) | |||
| 1- Month Post | 7.59 (6.20, 8.99) | 0.04 (−0.08, 0.16) | 6.78 (5.41, 8.14) | −0.04 (−0.15, 0.07) | 0.09 (−0.04, 0.21) |
| 4-Months Post | 7.66 (6.58, 8.74) | 0.07 (−0.10, 0.23) | 7.79 (6.69, 8.89) | 0.26 (0.14, 0.38)[ | −0.21 (−0.39, −0.04)[ |
|
| |||||
|
| |||||
| Baseline | 116.44 (106.82, 126.05) | 117.87 (107.86, 127.88) | |||
| 1- Month Post | 117.57 (108.31, 126.83) | 0.04 (−0.09, 0.18) | 119.61 (111.07, 128.16) | 0.06 (−0.05, 0.17) | −0.02 (−0.16, 0.12) |
| 4-Months Post | 115.14 (103.79, 126.50) | −0.05 (−0.22, 0.13) | 115.79 (103.45, 128.14) | −0.08 (−0.19, 0.04) | 0.03 (−0.15, 0.21) |
|
| |||||
| Baseline | 114.50 (104.88, 124.12) | 114.05 (102.85, 125.24) | |||
| 1- Month Post | 113.29 (102.28, 124.31) | −0.04 (−0.18, 0.09) | 112.76 (101.13, 124.38) | −0.04 (−0.15, 0.06) | 0.003 (−0.14, 0.14) |
| 4-Months Post | 113.54 (102.64, 124.44) | −0.04 (−0.19, 0.12) | 111.03 (98.93, 123.13) | −0.10 (−0.22, 0.02) | 0.07 (−0.09, 0.23) |
|
| |||||
|
| |||||
| Baseline | 20.86 (16.14, 25.58) | 22.23 (17.65, 26.81) | |||
| 1- Month Post | 16.83 (12.22, 21.45) | 0.30 (0.16, 0.44)[ | 20.96 (16.73, 25.19) | 0.10 (−0.01, 0.21) | 0.21 (0.07, 0.35)[ |
| 4-Months Post | 14.60 (9.06, 20.14) | 0.47 (0.29, 0.64)[ | 18.80 (14.45, 23.16) | 0.27 (0.16, 0.39)[ | 0.22 (0.04, 0.40)[ |
|
| |||||
| Baseline | 24.19 (19.15, 29.24) | 25.55 (20.58, 30.52) | |||
| 1- Month Post | 20.36 (15.69, 25.02) | 0.27 (0.13, 0.40)[ | 20.92 (16.33, 25.50) | 0.34 (0.23, 0.45)[ | −0.06 (−0.20, 0.08) |
| 4-Months Post | 22.96 (17.38, 28.54) | 0.09 (−0.07, 0.24) | 20.80 (15.91, 25.69) | 0.35 (0.23, 0.46)[ | −0.25 (−0.41, −0.09)[ |
|
| |||||
| Baseline | 59.84 (54.27, 65.40) | 58.42 (52.69, 64.15) | |||
| 1- Month Post | 63.62 (57.80, 69.44) | 0.24 (0.12, 0.36)[ | 62.73 (56.99, 68.47) | 0.27 (0.16, 0.39)[ | −0.03 (−0.16, 0.09) |
| 4-Months Post | 66.36 (60.42, 72.31) | 0.41 (0.25, 0.58)[ | 64.36 (58.72, 70.00) | 0.38 (0.26, 0.50)[ | 0.04 (−0.14, 0.21) |
|
| |||||
|
| |||||
| Baseline | 13.88 (10.62, 17.14) | 13.38 (10.40, 16.37) | |||
| 1- Month Post | 10.87 (7.37, 14.37) | 0.33 (0.19, 0.46)[ | 13.91 (10.63, 17.19) | −0.06 (−0.17, 0.05) | 0.40 (0.26, 0.55)[ |
| 4-Months Post | 12.54 (8.93, 16.15) | 0.15 (−0.02, 0.31) | 13.45 (10.37, 16.54) | −0.01 (−0.12, 0.10) | 0.16 (−0.01, 0.33) |
|
| |||||
| Baseline | 13.44 (10.28, 16.60) | 15.62 (12.66, 18.59) | |||
| 1- Month Post | 13.58 (9.62, 17.54) | −0.02 (−0.15, 0.12) | 14.66 (11.22, 18.10) | 0.12 (0.01, 0.23)[ | −0.13 (−0.27, −0.01)[ |
| 4-Months Post | 14.97 (11.64, 18.31) | −0.17 (−0.33, −0.02)[ | 15.66 (12.60, 18.73) | −0.005 (−0.12, 0.11) | −0.17 (−0.34, −0.01)[ |
|
| |||||
| Baseline | 19.28 (16.30, 22.27) | 17.84 (14.69, 20.99) | |||
| 1- Month Post | 16.36 (12.62, 20.11) | 0.34 (0.22, 0.47)[ | 17.20 (13.67, 20.74) | 0.07 (−0.04, 0.19) | 0.27 (0.14, 0.39)[ |
| 4-Months Post | 16.31 (12.81, 19.81) | 0.35 (0.19, 0.51)[ | 16.40 (12.82, 19.99) | 0.17 (0.05, 0.29)[ | 0.18 (0.02, 0.34)[ |
|
| |||||
|
| |||||
| Baseline | 6.22 (5.12, 7.32) | 5.81 (4.75, 6.87) | |||
| 1- Month Post | 6.48 (5.22, 7.74) | 0.08 (−0.05, 0.22) | 6.00 (4.85, 7.15) | 0.07 (−0.04, 0.18) | 0.02 (−0.12, 0.16) |
| 4-Months Post | 6.59 (5.44, 7.73) | 0.12 (−0.06, 0.29) | 5.71 (4.52, 6.89) | −0.04 (−0.15, 0.08) | 0.16 (−0.02, 0.34) |
|
| |||||
| Baseline | 5.51 (4.46, 6.56) | 5.97 (4.75, 7.19) | |||
| 1- Month Post | 5.23 (3.87, 6.58) | −0.09 (−0.23, 0.04) | 5.71 (4.36, 7.06) | −0.08 (−0.19, 0.03) | −0.01 (−0.15, 0.13) |
| 4-Months Post | 6.09 (4.65,7.53) | 0.20 (0.04, 0.35)[ | 5.80 (4.43, 7.17) | −0.05 (−0.17, 0.07) | 0.24 (0.07, 0.40)[ |
|
| |||||
| Baseline | 4.61 (3.44, 5.77) | 4.48 (3.26, 5.70) | |||
| 1- Month Post | 4.97 (3.92, 6.01) | 0.11 (−0.01, 0.23) | 4.88 (3.95, 5.80) | 0.12 (0.01, 0.23)[ | −0.01 (−0.13, 0.12) |
| 4-Months Post | 5.52 (4.46, 6.58) | 0.28 (0.11, 0.44)[ | 4.47 (3.53, 5.41) | −0.003 (−0.12, 0.12) | 0.28 (0.11, 0.45)[ |
Note:
95% CI for effect size does not include zero, which is equivalent to p ≤ 0.05.
Positive effect size reflects the desired therapy.